Laboratorio Farmaceutico Erfo S.p.A. (BIT:ERFO)
Italy
· Delayed Price · Currency is EUR 1.035
-0.020 (-1.90%)
Last updated: Apr 23, 2025
BIT:ERFO Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| Operating Revenue | 5.83 | 5.74 | 4.62 | 4.84 | 3.9 | Upgrade
|
| Other Revenue | 0.2 | 0.19 | 0.1 | 0.17 | 0.13 | Upgrade
|
| Revenue | 6.03 | 5.93 | 4.72 | 5.01 | 4.03 | Upgrade
|
| Revenue Growth (YoY) | 1.69% | 25.70% | -5.74% | 24.09% | -11.71% | Upgrade
|
| Cost of Revenue | 3.49 | 3.33 | 2.27 | 2.24 | 1.69 | Upgrade
|
| Gross Profit | 2.54 | 2.6 | 2.45 | 2.77 | 2.35 | Upgrade
|
| Selling, General & Admin | 1.49 | 1.24 | 1.04 | 0.81 | 0.69 | Upgrade
|
| Other Operating Expenses | -0.17 | -0.22 | -0.21 | -0.08 | -0.13 | Upgrade
|
| Operating Expenses | 2.01 | 1.76 | 1.46 | 1.19 | 0.86 | Upgrade
|
| Operating Income | 0.53 | 0.84 | 0.99 | 1.58 | 1.49 | Upgrade
|
| Interest Expense | -0.03 | -0.03 | -0.04 | -0.02 | -0.01 | Upgrade
|
| Interest & Investment Income | 0.03 | - | - | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | -0 | 0 | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | -0 | 0.01 | 0 | 0 | 0.01 | Upgrade
|
| EBT Excluding Unusual Items | 0.53 | 0.82 | 0.95 | 1.57 | 1.49 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | -0.01 | - | Upgrade
|
| Asset Writedown | -0.01 | - | - | - | - | Upgrade
|
| Pretax Income | 0.53 | 0.82 | 0.95 | 1.56 | 1.49 | Upgrade
|
| Income Tax Expense | 0.17 | 0.22 | 0.23 | 0.39 | 0.35 | Upgrade
|
| Net Income | 0.35 | 0.59 | 0.72 | 1.17 | 1.14 | Upgrade
|
| Net Income to Common | 0.35 | 0.59 | 0.72 | 1.17 | 1.14 | Upgrade
|
| Net Income Growth | -40.23% | -17.56% | -38.59% | 2.28% | -12.99% | Upgrade
|
| Shares Outstanding (Basic) | - | 9 | 9 | 2 | - | Upgrade
|
| Shares Outstanding (Diluted) | - | 9 | 9 | 2 | - | Upgrade
|
| Shares Change (YoY) | - | -4.44% | 500.00% | - | - | Upgrade
|
| EPS (Basic) | - | 0.07 | 0.08 | 0.78 | - | Upgrade
|
| EPS (Diluted) | - | 0.07 | 0.08 | 0.78 | - | Upgrade
|
| EPS Growth | - | -13.73% | -89.76% | - | - | Upgrade
|
| Free Cash Flow | 1.17 | 0.98 | 0.3 | 2.1 | 1.31 | Upgrade
|
| Free Cash Flow Per Share | - | 0.11 | 0.03 | 1.40 | - | Upgrade
|
| Dividend Per Share | - | 0.060 | - | - | - | Upgrade
|
| Gross Margin | 42.07% | 43.84% | 51.91% | 55.26% | 58.16% | Upgrade
|
| Operating Margin | 8.82% | 14.11% | 20.91% | 31.56% | 36.87% | Upgrade
|
| Profit Margin | 5.85% | 9.95% | 15.17% | 23.29% | 28.25% | Upgrade
|
| Free Cash Flow Margin | 19.46% | 16.58% | 6.39% | 41.87% | 32.56% | Upgrade
|
| EBITDA | 1.22 | 1.42 | 1.61 | 2.02 | 1.78 | Upgrade
|
| EBITDA Margin | 20.22% | 23.98% | 34.07% | 40.40% | 44.09% | Upgrade
|
| D&A For EBITDA | 0.69 | 0.59 | 0.62 | 0.44 | 0.29 | Upgrade
|
| EBIT | 0.53 | 0.84 | 0.99 | 1.58 | 1.49 | Upgrade
|
| EBIT Margin | 8.82% | 14.11% | 20.91% | 31.56% | 36.87% | Upgrade
|
| Effective Tax Rate | 32.96% | 27.58% | 24.50% | 25.06% | 23.54% | Upgrade
|
| Revenue as Reported | 6.34 | 6.26 | 5.03 | 5.13 | 4.2 | Upgrade
|
Updated Sep 26, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.